Baxter Heparin Recall
The product liability trial over flawed consignments of the blood thinner heparin, used throughout the United States from late 2007 to early 2008 was scheduled to begin in November 2010. A Baxter heparin recall was issued in January 2008 after a prickle in adverse event reports surfaced, which involved reactions to heparin, an anticoagulant that is critical for a number of medical procedures and conditions (DeNoon, 2008).
———Middle of paper———
Additionally, in 2008, the share price of Baxter Company dropped to around forty dollars per share. This was as a result of reduced investor confidence. The company was incurring significant losses, which lowered the demand for its shares. However, the share price has increased due to improved market performance.
Baxter International. (2013, November 22). Has A Buying Opportunity In Baxter International Occurred? Retrieved from Seeking Alpa.
DeNoon, D. (2008). No Heparin Shortage Predicted as Drugmaker APP Steps Up Production. WebMD Health News.
Do you need to sample other essays ?Check out all our blog posts where we have a wide variety of topics e.g. Compensation and Benefit Systems of Starbucks company
Are you ready to order a custom essay from us ? Place your order with us today.